Developer docs
API playgroundTry for free, no card

Search company profiles

AIRS Medical

Full company profile

uuid0000l1b

Namestring
AIRS Medical
Legal namestring
주식회사 에어스메디컬 (AIRS Medical Inc.)
Websiteurl
airsmed.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

AIRS Medical Inc. (주식회사 에어스메디컬) is a South Korea-based, privately held medical AI company founded in 2018 that develops AI-powered MRI image enhancement software for hospitals, imaging centers, and radiology practices. The company's flagship product, SwiftMR, uses deep learning reconstruction to reduce MRI scan times by up to 50% while improving image quality and operates across all major MRI scanner manufacturers (Siemens Healthineers, GE HealthCare, Philips, Canon Medical, Fonar, Esaote, ASG Superconductors) without requiring hardware replacement. The product line has expanded to include SwiftMR Turbo, a higher-performance acceleration variant, and SwiftSight, an AI-powered brain health quantification and reporting solution for longitudinal assessment across scanner vendors and field strengths.

The company monetizes through subscription-based per-equipment and per-user licensing, with enterprise site licenses for large imaging networks such as SimonMed (nationwide rollout in the United States). Distribution combines direct enterprise field sales with a global Approved Source reseller network (including mediaire in DACH) and OEM integration partnerships that embed SwiftMR into manufacturers' MRI systems. Operations span headquarters in Seoul, regional offices in Tokyo, Schaumburg (US), and Munich, and wholly-owned subsidiaries in the US, Europe, and Japan; commercially deployed across 40+ countries and 1,700+ healthcare institutions, processing 7M+ MRI examinations annually.

AIRS Medical has accumulated regulatory and security credentials including FDA 510(k) clearance, CE MDR certification, MFDS approval, HIPAA, GDPR, SOC 2 Type II, ISO 27001:2022, and HITRUST e1. The company has raised approximately $39M+ across multiple rounds (Series A with Springcamp and TIPS, Series B ~$20M led by Q Capital Partners and Hanwha Life in 2022, Series C of 27B KRW in 2024) and in 2026 announced a strategic growth investment from TA Associates to fund global expansion, with notable prior recognition including Forbes Korea AI 50 (2024) and CB Insights Top 50 Digital Health Companies (2024).

Short descriptiontext

AIRS Medical is a South Korea-based AI medical imaging company that develops SwiftMR, an FDA-cleared deep learning MRI enhancement solution reducing scan times by up to 50%. It serves 1,700+ hospitals, imaging centers, and radiology practices across 40+ countries via vendor-neutral, subscription-based enterprise deployments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDoksansadong, South Korea
HQ citystring
Doksansadong
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI-powered MRI enhancement, MRI reconstruction software, medical imaging AI, deep learning MRI acceleration, brain health quantification
Industry4 codes
1AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
CodeHLACALAGPrimaryYes
2Radiology AI, CAD & Advanced Visualization Software
CodeHLAHABAJPrimaryNo
3SaMD – Imaging & Signal Analysis (AI/ML)
CodeHLACANAGPrimaryNo
4Medical Imaging AI
CodeHDAAAEAHPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging AI Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software Subscription License
TypeSubscription Recurring
Description

Subscription-based licensing model for SwiftMR software with license keys tied to specific MRI and PACS equipment. Usage limits expressed in terms of number of Authorized Equipment and Authorized Users. Revenue recognized over subscription term.

airsmed.com
2Enterprise Site Licenses
TypeSubscription Recurring
Description

Site-wide deployments for large healthcare organizations and imaging networks. Multi-equipment licensing with tiered pricing based on number of scanners and users.

airsmed.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Subscription-based licensing with per-equipment and per-user pricing
ModelSubscriptionBilling cadenceAnnual
Notes

License keys are unique to specific MRI and PACS equipment and cannot be shared. Login credentials are unique to individual authorized users. Subscription term and pricing negotiated through Approved Source (resellers/distributors).

airsmed.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

AIRS Medical develops and sells AI-powered MRI enhancement software that uses deep learning to reduce MRI scan times by up to 50% and improve image quality across all major scanner manufacturers without hardware replacement. Its core products—SwiftMR (image enhancement and scan acceleration), SwiftMR Turbo (next-generation acceleration), and SwiftSight (brain health quantification)—are sold as subscription licenses to hospitals, imaging centers, and OEM partners globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduces MRI scan times by 30-50%
+4 more records
Product overview1 text field

AIRS Medical offers a unified AI platform for MRI enhancement, consisting of three main products: SwiftMR (core AI-powered MRI enhancement solution), SwiftMR Turbo (next-generation acceleration product), and SwiftSight (brain health quantification add-on). SwiftMR reduces MRI scan times by up to 50% while improving image quality, and SwiftSight adds quantitative brain imaging analysis capabilities for longitudinal monitoring. The platform is vendor-neutral and deploys across mixed MRI scanner fleets from Siemens Healthineers, GE HealthCare, Philips, and Canon Medical without requiring hardware replacement.

Product and service3 records
1SwiftMR®
CategoryAI MRI Image Enhancement Software
Description

FDA 510(k)-cleared AI-powered MRI image enhancement software that reduces MRI scan times by up to 50% and improves image quality. Vendor-neutral and compatible with all major MRI scanner manufacturers (Siemens Healthineers, GE HealthCare, Philips, Canon Medical) without hardware replacement. Sold to hospitals, imaging centers, and radiology practices via subscription license.

2SwiftMR Turbo
CategoryAI MRI Scan Acceleration Software
Description

Next-generation MRI acceleration product that significantly reduces scan times beyond the standard SwiftMR offering, expanding AIRS Medical's MRI scan acceleration portfolio for global customers.

3SwiftSight®
CategoryAI Brain Health Quantification Software
Description

AI-powered brain health quantification and reporting solution that generates reproducible quantitative brain MRI measurements for longitudinal assessment, clinical research, and objective decision-making across different MRI scanner vendors and field strengths. Sold to radiologists, neurologists, and imaging providers for brain health monitoring.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-25
Description

Strengthened partnership for Open MRI integration, bringing SwiftMR capabilities to Esaote's Open MRI systems. Expanded distribution through Esaote's customer base.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-25
Description

Partnership to bring SwiftMR capabilities to ASG's MROpen EVO upright MRI systems, enabling AI-enhanced imaging in sitting/standing position MRI scans.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Leading MRI AI company in Europe and key partner in DACH region that initiated and supported Röntgenpraxis Am Marstall's SwiftMR adoption. Regional distribution partner.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Enterprise-wide deployment of SwiftMR across SimonMed's nationwide imaging network following comprehensive evaluation. One of the nation's largest independent outpatient imaging providers.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Pixyl provides AI-based brain MRI analysis for multiple sclerosis and neurodegenerative disease, targeting similar neurology and radiology customers as SwiftSight with a narrower clinical focus.

TypeDirect peer
Description

Subtle Medical develops AI-powered MRI and PET image enhancement software (SubtleMR, SubtleMedical) that reduces scan times and improves image quality, closely mirroring AIRS Medical's SwiftMR product, target customers (hospitals and imaging centers), and business model.

TypeBroad incumbent
Description

GE HealthCare is a major MRI OEM whose AIR Recon DL deep-learning reconstruction is a direct functional competitor to SwiftMR on GE scanners, but operates as part of a much broader imaging and diagnostics portfolio rather than as a focused AI imaging software vendor.

TypeBroad incumbent
Description

Siemens Healthineers offers Deep Resolve and other AI-based MRI reconstruction as part of its scanner sales. It is both a compatibility partner for SwiftMR and a competitor via its native AI reconstruction pipeline.

TypeBroad incumbent
Description

Philips offers SmartSpeed and Compressed SENSE AI acceleration on its MRI scanners. It is a SwiftMR compatibility partner and a competitor through its embedded AI reconstruction offering.

TypeDirect peer
Description

mediaire is a European MRI AI vendor (mdbrain, mdprostate) and a regional channel partner for AIRS Medical in DACH. It offers overlapping AI brain and prostate imaging capabilities, serving the same radiology customer base in Europe.

TypeEmerging player
Description

Cortechs.ai provides AI-based quantitative MRI analysis (e.g., NeuroQuant) for brain and prostate imaging, overlapping with SwiftSight's longitudinal brain quantification use case, though focused on measurement rather than image enhancement.

TypeEmerging player
Description

icometrix develops AI software (icobrain) for quantitative brain MRI analysis in clinical practice and clinical trials, directly competing with SwiftSight's brain health quantification and reporting positioning.

TypeEmerging player
Description

SyntheticMR offers SyMRI and MAGiC, quantitative MRI software that generates tissue property measurements from a single scan, conceptually adjacent to SwiftSight's quantitative brain imaging and longitudinal analysis use case.

TypeOthers
Description

Ezra is an AI-driven full-body MRI screening provider that leverages AI for faster, more accessible MRI scanning. It uses AI MRI enhancement technology in a consumer-facing screening model, adjacent to AIRS Medical's provider-facing imaging AI platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AIRS Medical

Medical Imaging AI Softwareairsmed.com

AIRS Medical is a South Korea-based AI medical imaging company that develops SwiftMR, an FDA-cleared deep learning MRI enhancement solution reducing scan times by up to 50%. It serves 1,700+ hospitals, imaging centers, and radiology practices across 40+ countries via vendor-neutral, subscription-based enterprise deployments.

What AIRS Medical does

AIRS Medical Inc. (주식회사 에어스메디컬) is a South Korea-based, privately held medical AI company founded in 2018 that develops AI-powered MRI image enhancement software for hospitals, imaging centers, and radiology practices. The company's flagship product, SwiftMR, uses deep learning reconstruction to reduce MRI scan times by up to 50% while improving image quality and operates across all major MRI scanner manufacturers (Siemens Healthineers, GE HealthCare, Philips, Canon Medical, Fonar, Esaote, ASG Superconductors) without requiring hardware replacement. The product line has expanded to include SwiftMR Turbo, a higher-performance acceleration variant, and SwiftSight, an AI-powered brain health quantification and reporting solution for longitudinal assessment across scanner vendors and field strengths.

The company monetizes through subscription-based per-equipment and per-user licensing, with enterprise site licenses for large imaging networks such as SimonMed (nationwide rollout in the United States). Distribution combines direct enterprise field sales with a global Approved Source reseller network (including mediaire in DACH) and OEM integration partnerships that embed SwiftMR into manufacturers' MRI systems. Operations span headquarters in Seoul, regional offices in Tokyo, Schaumburg (US), and Munich, and wholly-owned subsidiaries in the US, Europe, and Japan; commercially deployed across 40+ countries and 1,700+ healthcare institutions, processing 7M+ MRI examinations annually.

AIRS Medical has accumulated regulatory and security credentials including FDA 510(k) clearance, CE MDR certification, MFDS approval, HIPAA, GDPR, SOC 2 Type II, ISO 27001:2022, and HITRUST e1. The company has raised approximately $39M+ across multiple rounds (Series A with Springcamp and TIPS, Series B ~$20M led by Q Capital Partners and Hanwha Life in 2022, Series C of 27B KRW in 2024) and in 2026 announced a strategic growth investment from TA Associates to fund global expansion, with notable prior recognition including Forbes Korea AI 50 (2024) and CB Insights Top 50 Digital Health Companies (2024).

AIRS Medical firmographics

Firmographics
Name
AIRS Medical
Legal name
주식회사 에어스메디컬 (AIRS Medical Inc.)
Website
https://airsmed.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
AIRS Medical is a South Korea-based AI medical imaging company that develops SwiftMR, an FDA-cleared deep learning MRI enhancement solution reducing scan times by up to 50%. It serves 1,700+ hospitals, imaging centers, and radiology practices across 40+ countries via vendor-neutral, subscription-based enterprise deployments.
Ownership category
akta.pro rank

AIRS Medical industry classification

Industry
Product category
Medical Imaging AI Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
akta.pro secondary industries
Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Medical Imaging AI (HDAAAEAH)

Keywords

  • AI-powered MRI enhancement
  • MRI reconstruction software
  • Medical imaging AI
  • Deep learning MRI acceleration
  • Brain health quantification

Where AIRS Medical is headquartered

Location

Headquarters

HQ city
Doksansadong
HQ country
South Korea
HQ region
Asia

Offices4 records

Markets served

AIRS Medical business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Subscription License: Subscription-based licensing model for SwiftMR software with license keys tied to specific MRI and PACS equipment. Usage limits expressed in terms of number of Authorized Equipment and Authorized Users. Revenue recognized over subscription term.
  2. Enterprise Site Licenses: Site-wide deployments for large healthcare organizations and imaging networks. Multi-equipment licensing with tiered pricing based on number of scanners and users.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSubscription-based licensing with per-equipment and per-user pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

AIRS Medical product offering

Product offering

Core offering

AIRS Medical develops and sells AI-powered MRI enhancement software that uses deep learning to reduce MRI scan times by up to 50% and improve image quality across all major scanner manufacturers without hardware replacement. Its core products—SwiftMR (image enhancement and scan acceleration), SwiftMR Turbo (next-generation acceleration), and SwiftSight (brain health quantification)—are sold as subscription licenses to hospitals, imaging centers, and OEM partners globally.

Product overview

AIRS Medical offers a unified AI platform for MRI enhancement, consisting of three main products: SwiftMR (core AI-powered MRI enhancement solution), SwiftMR Turbo (next-generation acceleration product), and SwiftSight (brain health quantification add-on). SwiftMR reduces MRI scan times by up to 50% while improving image quality, and SwiftSight adds quantitative brain imaging analysis capabilities for longitudinal monitoring. The platform is vendor-neutral and deploys across mixed MRI scanner fleets from Siemens Healthineers, GE HealthCare, Philips, and Canon Medical without requiring hardware replacement.

Differentiator

Problem solved

Functional benefit

Products and services

  • SwiftMR® FDA 510(k)-cleared AI-powered MRI image enhancement software that reduces MRI scan times by up to 50% and improves image quality. Vendor-neutral and compatible with all major MRI scanner manufacturers (Siemens Healthineers, GE HealthCare, Philips, Canon Medical) without hardware replacement. Sold to hospitals, imaging centers, and radiology practices via subscription license.
  • SwiftMR Turbo Next-generation MRI acceleration product that significantly reduces scan times beyond the standard SwiftMR offering, expanding AIRS Medical's MRI scan acceleration portfolio for global customers.
  • SwiftSight® AI-powered brain health quantification and reporting solution that generates reproducible quantitative brain MRI measurements for longitudinal assessment, clinical research, and objective decision-making across different MRI scanner vendors and field strengths. Sold to radiologists, neurologists, and imaging providers for brain health monitoring.

Quantifiable outcome

  • Reduces MRI scan times by 30-50%
  • +4 more outcomes

Companies that use AIRS Medical

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

AIRS Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability4 records

Feature5 records

AIRS Medical partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and flagship.

  • EsaotecoreTechnology or Integration · 25 February 2026Strengthened partnership for Open MRI integration, bringing SwiftMR capabilities to Esaote's Open MRI systems. Expanded distribution through Esaote's customer base.
  • ASG SuperconductorscoreTechnology or Integration · 25 February 2026Partnership to bring SwiftMR capabilities to ASG's MROpen EVO upright MRI systems, enabling AI-enhanced imaging in sitting/standing position MRI scans.
  • mediairecoreChannel Partner/ Reseller/ DistributorLeading MRI AI company in Europe and key partner in DACH region that initiated and supported Röntgenpraxis Am Marstall's SwiftMR adoption. Regional distribution partner.
  • SimonMedflagshipStrategic or Co-development PartnerEnterprise-wide deployment of SwiftMR across SimonMed's nationwide imaging network following comprehensive evaluation. One of the nation's largest independent outpatient imaging providers.

Scale indicators14 records

Recent moves7 records

Expansion highlights8 records

AIRS Medical competitors and assessment

Company assessment

Emerging players

  • Pixyl: Pixyl provides AI-based brain MRI analysis for multiple sclerosis and neurodegenerative disease, targeting similar neurology and radiology customers as SwiftSight with a narrower clinical focus.
  • Cortechs.ai: Cortechs.ai provides AI-based quantitative MRI analysis (e.g., NeuroQuant) for brain and prostate imaging, overlapping with SwiftSight's longitudinal brain quantification use case, though focused on measurement rather than image enhancement.
  • icometrix: icometrix develops AI software (icobrain) for quantitative brain MRI analysis in clinical practice and clinical trials, directly competing with SwiftSight's brain health quantification and reporting positioning.
  • SyntheticMR: SyntheticMR offers SyMRI and MAGiC, quantitative MRI software that generates tissue property measurements from a single scan, conceptually adjacent to SwiftSight's quantitative brain imaging and longitudinal analysis use case.

Direct peers

  • Subtle Medical: Subtle Medical develops AI-powered MRI and PET image enhancement software (SubtleMR, SubtleMedical) that reduces scan times and improves image quality, closely mirroring AIRS Medical's SwiftMR product, target customers (hospitals and imaging centers), and business model.
  • mediaire: mediaire is a European MRI AI vendor (mdbrain, mdprostate) and a regional channel partner for AIRS Medical in DACH. It offers overlapping AI brain and prostate imaging capabilities, serving the same radiology customer base in Europe.

Broad incumbents

  • GE HealthCare: GE HealthCare is a major MRI OEM whose AIR Recon DL deep-learning reconstruction is a direct functional competitor to SwiftMR on GE scanners, but operates as part of a much broader imaging and diagnostics portfolio rather than as a focused AI imaging software vendor.
  • Siemens Healthineers: Siemens Healthineers offers Deep Resolve and other AI-based MRI reconstruction as part of its scanner sales. It is both a compatibility partner for SwiftMR and a competitor via its native AI reconstruction pipeline.
  • Philips: Philips offers SmartSpeed and Compressed SENSE AI acceleration on its MRI scanners. It is a SwiftMR compatibility partner and a competitor through its embedded AI reconstruction offering.

Others

  • Ezra: Ezra is an AI-driven full-body MRI screening provider that leverages AI for faster, more accessible MRI scanning. It uses AI MRI enhancement technology in a consumer-facing screening model, adjacent to AIRS Medical's provider-facing imaging AI platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

AIRS Medical social profiles

Digital presence

AIRS Medical compliance and trust

Trust signal

Compliance6 records

AIRS Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AIRS Medical leadership team

Management profile

Number of profiles

Profiles4 records

AIRS Medical subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

AIRS Medical funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AIRS Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIRS Medical

What does AIRS Medical do?

AIRS Medical develops and sells AI-powered MRI enhancement software that uses deep learning to reduce MRI scan times by up to 50% and improve image quality across all major scanner manufacturers without hardware replacement. Its core products—SwiftMR (image enhancement and scan acceleration), SwiftMR Turbo (next-generation acceleration), and SwiftSight (brain health quantification)—are sold as subscription licenses to hospitals, imaging centers, and OEM partners globally.

Is AIRS Medical a public or private company?

AIRS Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was AIRS Medical founded?

AIRS Medical was founded in 2018. It employs 51 to 100 people.

Where is AIRS Medical based?

AIRS Medical is headquartered in Doksansadong, South Korea, in the Asia region.

How does AIRS Medical make money?

Two revenue lines are on record. Software Subscription License is the primary driver. The others are enterprise Site Licenses.

Who are AIRS Medical's main competitors?

Emerging players on record are Pixyl, Cortechs.ai, icometrix and SyntheticMR. Direct peers are Subtle Medical and mediaire. Broad incumbents are GE HealthCare, Siemens Healthineers and Philips. Ezra is listed as an others.

Does AIRS Medical have an API?

No public API is recorded for AIRS Medical.

What industry is AIRS Medical in?

AIRS Medical's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Unite.AIFDA Clears AIRS Medical’s AI MRI Tool for Body Composition AnalysisThe FDA granted 510(k) clearance for AIRS Medical's SwiftSight Body Composition AI MRI software on October 5, 2026, with SimonMed Imaging as the first customer. The software quantifies muscle, fat, and liver fat from sub-five-minute scans, targeting preventive health and weight management. The company plans to showcase the product at RSNA 2026.PR NewswireAIRS Medical Receives FDA 510(k) Clearance for SwiftSight® Body CompositionAIRS Medical received FDA 510(k) clearance for SwiftSight Body Composition, an AI-powered MRI solution for body composition analysis. The solution quantifies muscle, adipose tissue, and liver fat in under five minutes, with SimonMed Imaging as the first customer. The company plans to expand the platform with diffusion tensor imaging in November 2026.KBRAIRS Medical cut its US team amid a major deal and new funding, ex-staffers sayAIRS Medical, a Korean AI-MRI startup, cut US and Europe staff this spring, with three former employees reporting layoffs. The departures came as the company finalized a nationwide deployment deal with a major US imaging provider and prepared to announce new funding from a private equity firm.WowtaleAIRS Medical Lands Follow-On Investment from Dunamu&Partners, Reaching $6.2M to Fuel Global ExpansionDunamu & Partners has made a follow-on investment in AIRS Medical, a Korean AI-powered medical imaging company, bringing cumulative investment to $6.24 million. The funding will support AIRS Medical's expansion into US and European markets, advancement of next-generation AI technology, and further clinical application development. AIRS Medical's solutions, including MRI time-reduction technology SwiftMR and quantification platform SwiftSight, are currently deployed at over 1,700 medical institutions across more than 40 countries, supporting 6 million AI-assisted scans annually.The SaaS NewsAIRS Medical Secures Strategic Growth InvestmentAIRS Medical, an AI-native medical imaging company headquartered in Hong Kong and Seoul, has secured a strategic growth investment from TA Associates, a leading global private equity firm. The funding will be used to accelerate global expansion, advance AI-powered radiology technology solutions, and support ongoing product innovation for healthcare providers. Founded in 2018, AIRS Medical develops MRI acceleration and reconstruction software including SwiftMR and SwiftSight.VenturesquareMRI has penetrated the global market with AI... Dunamu & Partners makes an additional bet on Airs Medical.Dunamu & Partners made a follow-up investment in AI medical imaging firm Airs Medical, with cumulative investment reaching 9.7 billion won. Global PE firm TA Associates also participated, supporting Airs Medical's overseas expansion. The company plans to use funds for global market growth and product development.StartuptodayDunamu & Partners continuously invests in the medical AI company Airs Medical... achieving a total of 9.7 billion won.Dunamu & Partners made a follow-up investment in AIRS Medical, bringing total investment to 9.7 billion won, with TA Associates joining. AIRS Medical's AI MRI solutions are used in over 1,700 institutions across 40 countries. The company plans to expand in the U.S. and Europe and develop next-generation AI.PlatumDunamu & Partners, follow-up investment in AI medical imaging solution 'Airs Medical'... a total investment of 9.7 billion wonDunamu & Partners executed a follow-up investment in AI medical imaging firm AIRS Medical, bringing its cumulative stake to 9.7 billion won. The round, led by TA Associates, funds expansion in the U.S. and Europe and development of new AI-based MRI solutions.Via TTAIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI SolutionsAIRS Medical, a South Korean AI medical imaging company, announced receiving a strategic growth investment from private equity firm TA Associates to accelerate global expansion and product innovation of its AI-powered MRI solutions. The company, founded in 2018, supports over 1,700 healthcare institutions across more than 40 countries, with its technologies used in over 6 million MRI examinations annually. The transaction is expected to close in Q2 2026, subject to customary closing conditions, with financial terms not disclosed.BioWorldFinancings for June 23, 2026On June 23, 2026, biopharma and med-tech companies in Asia-Pacific raised funds through public or private financings. The companies listed are Airs Medical, Gero AI, Multivalent Biotherapies, Coherent, and Racura Oncology.